Jpr Labs Profile
Key Indicators
- Authorised Capital ₹ 61.00 Cr
as on 05-12-2024
- Paid Up Capital ₹ 49.69 Cr
as on 05-12-2024
- Company Age 14 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 38.50 Cr
as on 05-12-2024
- Satisfied Charges ₹ 110.00 Cr
as on 05-12-2024
About Jpr Labs
The Corporate was formerly known as Annapurna Labs Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 61.00 Cr and a paid-up capital of Rs 49.69 Cr.
The company currently has active open charges totaling ₹38.50 Cr. The company has closed loans amounting to ₹110.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Jpr Labs Private Limited India are Vivek Aggarwal as COMPANY SECRETARY and Chirag Khetarpal as Cfo. Anil Tyagi, Abhay Srivastava, and Birendra Singh serve as directors at the Company.
- CIN/LLPIN
U24232DL2010PTC365041
- Company No.
069282
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jul 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Jpr Labs?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Aggarwal  | Company Secretary | 01-Jan-2019 | Current |
| Chirag Khetarpal | CFO | 15-Mar-2019 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Abhay Srivastava | Director | 01-Mar-2018 | Current |
| Anil Tyagi | Director | 01-Mar-2018 | Current |
| Birendra Singh | Whole-Time Director | 30-Apr-2024 | Current |
Financial Performance and Corporate Structure Insights of Jpr Labs.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Jpr Labs?
Unlock access to Jpr Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Mankind Life Sciences Private LimitedActive 4 years 3 monthsAnil Tyagi and Abhay Srivastava are mutual person
- Mankind Petcare Private LimitedActive 3 years 2 months
Anil Tyagi and Abhay Srivastava are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Jul 2024 | ₹3.50 Cr | Open |
Hdfc Bank Limited Creation Date: 01 Dec 2022 | ₹35.00 Cr | Open |
Others Creation Date: 20 Jan 2023 | ₹3.50 Cr | Satisfied |
How Many Employees Work at Jpr Labs?
Unlock and access historical data on people associated with Jpr Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jpr Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jpr Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
